HIGH COSTS CITED AS MAJOR REASON PATIENTS DO NOT ADHERE TO THEIR TREATMENTS
By Robert S. Bader, M.D., Dermatologist |
Has anybody seen the changes in the cost of medications lately? In case you have not noticed, they have soared ...
Read More 
HYDROCHLOROTHIAZIDE (HCTZ) USE IS ASSOCIATED WITH INCREASED RISK OF BASAL CELL AND SQUAMOUS CELL CARCINOMA
By Robert S. Bader, M.D., Dermatologist |
A recent study published in the Journal of the American Academy of Dermatology has shown that taking hydrochlorothiazide (HCTZ) is ...
Read More 
NEW DRUGS FOR PSORIASIS LOOKING GREAT!
By Robert S. Bader, M.D., Dermatologist |
TYK2 inhibitor is being developed by Bristol-Myers Squibb and the early Phase II trial results have been great. Why? Here is the ...
Read More 
THERE IS NO REASON TO RE-EXCISE A MODERATELY-ATYPICAL NEVUS
By Robert S. Bader, M.D., Dermatologist |
To those who are patients and those who follow my posts, you know that I am adamant that there has ...
Read More